Castle Biosciences (CSTL) FCF Margin Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 379.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 183.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 1,284.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 454.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 97.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -192.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -537.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 590.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -71.00 |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn | -708.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -708.00 |
| Mar 31, 2026 | -1,909.00 |
| Dec 31, 2025 | 2,360.00 |
| Sep 30, 2025 | -4,140.00 |
| Jun 30, 2025 | 988.00 |
| Mar 31, 2025 | -192.00 |
| Dec 31, 2024 | -1,366.00 |
| Sep 30, 2024 | 3,798.00 |
| Jun 30, 2024 | 2,746.00 |
| Mar 31, 2024 | 5,813.00 |
| Dec 31, 2023 | 6,851.00 |
| Sep 30, 2023 | 1,645.00 |
| Jun 30, 2023 | 1,533.00 |
| Mar 31, 2023 | 1,147.00 |
| Dec 31, 2022 | -1,691.00 |
| Sep 30, 2022 | 1,463.00 |
| Jun 30, 2022 | -593.00 |
| Mar 31, 2022 | -6,072.00 |
| Dec 31, 2021 | -3,172.00 |
| Sep 30, 2021 | 502.00 |